Sunshine Biopharma Inc (SBFM)

[TheHungryHippo]

Pursuant to the terms of the Lonza Agreement, Lonza will manufacture our drug in accordance with current Good Manufacturing Practices ("cGMP") in compliance with the regulations applicable in the U.S., Canada, Europe and other countries around the world relating to the manufacturing of medicinal products for human use. Lonza will build a master drug file for our Adva-27a drug and will have it ready for filing with regulatory authorities as may be required to secure ultimate drug approval. The Lonza Agreement provides for us to maintain one representative of our Company at their facility during the manufacturing process. Quality assurance and control is the responsibility of both Lonza and us during the process.

We have the right to inspect, test and approve all batches to insure compliance with the manufacturing specifications, which is required to be completed within 30 days after release of a batch. In the event of a dispute regarding compliance with the manufacturing specifications, the dispute will be resolved ultimately by independent analysis and testing. The Lonza Agreement contains customary warranties and disclaimers, confidentiality provisions as well as mutual indemnifications common in agreements of this type.


Lonza to take $SBFM to the finish line with this. I am not saying we should to wait around for this..

but I speculate IND application, the transition from pre-clinical into Phase 1 clinical trials for Anti-Cancer Compound, and the DEL drug license that allows us to sell pharmaceuticals, ...

are all catalyst that are upcoming short term, that can lift this stock to .05 + imo.